Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - MERRIMACK PHARMACEUTICALS INC | d851670dex311.htm |
EX-32.2 - EX-32.2 - MERRIMACK PHARMACEUTICALS INC | d851670dex322.htm |
EX-21.1 - EX-21.1 - MERRIMACK PHARMACEUTICALS INC | d851670dex211.htm |
EX-10.9 - EX-10.9 - MERRIMACK PHARMACEUTICALS INC | d851670dex109.htm |
EX-10.6 - EX-10.6 - MERRIMACK PHARMACEUTICALS INC | d851670dex106.htm |
EX-31.2 - EX-31.2 - MERRIMACK PHARMACEUTICALS INC | d851670dex312.htm |
EX-10.33 - EX-10.33 - MERRIMACK PHARMACEUTICALS INC | d851670dex1033.htm |
EX-10.15 - EX-10.15 - MERRIMACK PHARMACEUTICALS INC | d851670dex1015.htm |
EX-10.22 - EX-10.22 - MERRIMACK PHARMACEUTICALS INC | d851670dex1022.htm |
EXCEL - IDEA: XBRL DOCUMENT - MERRIMACK PHARMACEUTICALS INC | Financial_Report.xls |
10-K - FORM 10-K - MERRIMACK PHARMACEUTICALS INC | d851670d10k.htm |
EX-32.1 - EX-32.1 - MERRIMACK PHARMACEUTICALS INC | d851670dex321.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-3 (Nos. 333-186369 and 333-194312) and S-8 (Nos. 333-180996, 333-186370 and 333-194313) of Merrimack Pharmaceuticals, Inc. of our report dated February 27, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 27, 2015